Advertisement
Screener

PHARMACYCLICS INC Share-based Payment Arrangement, Expense

PHARMACYCLICS INC Share-based Payment Arrangement, Expense

PHARMACYCLICS INC reported Share-based Payment Arrangement, Expense of $23.50 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-04.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2015-05-04

  • PHARMACYCLICS INC share-based payment arrangement, expense for the quarter ending 2015-03-31 was $23.50M, a 80.93% increase year-over-year.
  • PHARMACYCLICS INC share-based payment arrangement, expense for the quarter ending 2014-12-31 was $11.53M, a 19.66% increase year-over-year.
  • PHARMACYCLICS INC share-based payment arrangement, expense for the quarter ending 2014-09-30 was $12.04M, a 18.74% increase year-over-year.
  • PHARMACYCLICS INC share-based payment arrangement, expense for the quarter ending 2014-06-30 was $17.19M, a 150.56% increase year-over-year.
  • PHARMACYCLICS INC share-based payment arrangement, expense for fiscal 2014 was $53.74M, a 7.03% increase from fiscal 2013.
  • PHARMACYCLICS INC share-based payment arrangement, expense for fiscal 2013 was $50.21M.
  • PHARMACYCLICS INC share-based payment arrangement, expense for fiscal 2012 was $9.87M, a 26.29% increase from fiscal 2011.
  • PHARMACYCLICS INC share-based payment arrangement, expense for fiscal 2011 was $7.82M, a 145.08% increase from fiscal 2010.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2015-03-31$23.50M
10-Q · filed 2015-05-04
$35.02M
derived: sum of 2 quarters · filed 2015-05-04
$47.06M
derived: sum of 3 quarters · filed 2015-05-04
$64.25M
derived: sum of 4 quarters · filed 2015-05-04
2014-12-31$11.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$23.56M
derived: sum of 2 quarters · filed 2015-02-18
$40.76M
derived: sum of 3 quarters · filed 2015-02-18
$53.74M
10-K · filed 2015-02-18
2014-09-30$12.04M
10-Q · filed 2014-11-07
$29.23M
derived: sum of 2 quarters · filed 2014-11-07
$42.21M
10-Q · filed 2014-11-07
$51.85M
derived: sum of 4 quarters · filed 2015-05-04
2014-06-30$17.19M
10-Q · filed 2014-08-08
$30.18M
10-Q · filed 2014-08-08
$39.81M
derived: sum of 3 quarters · filed 2015-05-04
$49.95M
derived: sum of 4 quarters · filed 2015-05-04
2014-03-31$12.99M
10-Q · filed 2015-05-04
$22.62M
derived: sum of 2 quarters · filed 2015-05-04
$32.76M
derived: sum of 3 quarters · filed 2015-05-04
$39.62M
derived: sum of 4 quarters · filed 2015-05-04
2013-12-31$9.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$19.77M
derived: sum of 2 quarters · filed 2015-02-18
$26.63M
derived: sum of 3 quarters · filed 2015-02-18
$50.21M
10-K · filed 2015-02-18
2013-09-30$10.14M
10-Q · filed 2014-11-07
$17.00M
derived: sum of 2 quarters · filed 2014-11-07
$40.58M
10-Q · filed 2014-11-07
$44.84M
derived: sum of 4 quarters · filed 2015-02-18
2013-06-30$6.86M
10-Q · filed 2014-08-08
$30.44M
10-Q · filed 2014-08-08
$34.71M
derived: sum of 3 quarters · filed 2015-02-18
$37.88M
derived: sum of 4 quarters · filed 2015-02-18
2013-03-31$23.58M
10-Q · filed 2014-05-08
$27.85M
derived: sum of 2 quarters · filed 2015-02-18
$31.01M
derived: sum of 3 quarters · filed 2015-02-18
$32.86M
derived: sum of 4 quarters · filed 2015-02-18
2012-12-31$4.27M
derived: 10-K 6 month − 10-Q 3 month · filed 2015-02-18
$7.44M
10-K · filed 2015-02-18
$9.28M
derived: sum of 3 quarters · filed 2015-02-18
$12.77M
derived: sum of 4 quarters · filed 2015-02-18
2012-09-30$3.17M
10-Q · filed 2013-11-07
$5.01M
derived: sum of 2 quarters · filed 2013-11-07
$8.50M
10-Q · filed 2013-11-07
2012-06-30$1.85M
10-Q · filed 2013-08-08
$5.33M
10-Q · filed 2013-08-08
$9.87M
10-K · filed 2015-02-18
2012-03-31$3.48M
10-Q · filed 2013-05-07
2011-09-30$2.16M
10-Q · filed 2012-11-07
2011-06-30$7.82M
10-K · filed 2014-02-26
2010-06-30$3.19M
10-KT · filed 2013-02-28